# Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?

> **NCT00279552** · PHASE2 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 37 (—)

## Conditions studied

- Vitamin B12 Deficiency

## Interventions

- **DRUG:** Recombinant human intrinsic factor

## Key facts

- **NCT ID:** NCT00279552
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 37 (—)
- **Last updated:** 2006-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00279552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00279552, "Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00279552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*